This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Washington University. Active years: 2013-2015.
Company Filing History:
Years Active: 2013-2015
Title: John R Sedy: Innovator in Lymphocyte Modulation
Introduction
John R Sedy is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of immunology, particularly in the modulation of lymphocyte activity. With a total of 2 patents, his work has implications for therapeutic, diagnostic, and research purposes.
Latest Patents
Sedy's latest patents focus on compositions and methods for modulating lymphocyte activity. One of his key inventions introduces a novel lymphocyte inhibitory receptor termed BTLA, which is expressed on both T and B cells. This invention identifies HVEM as an interacting partner with BTLA. The methods and compositions developed by Sedy aim to modulate BTLA-mediated signaling and interfere with the interaction of BTLA and HVEM.
Career Highlights
John R Sedy is affiliated with Washington University, where he continues to advance research in immunology. His innovative approaches have garnered attention in the scientific community, contributing to a deeper understanding of lymphocyte regulation.
Collaborations
Sedy has collaborated with notable colleagues, including Kenneth M Murphy and Theresa L Murphy. Their joint efforts have further enriched the research landscape in the field of lymphocyte modulation.
Conclusion
John R Sedy's contributions to the field of immunology through his patents and research at Washington University highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic and diagnostic applications.